COMPOUNDS ACT AT MULTIPLE PROSTAGLANDIN RECEPTORS GIVING A GENERAL ANTI-INFLAMMATORY RESPONSE
申请人:Allergan, Inc.
公开号:US20150080446A1
公开(公告)日:2015-03-19
The present invention provides a compound, that is a 1-[(2-[(alkyl or aryl)methyl]oxy}halo or haloalkyl substituted-phenyl)alkyl]-5-hydrocarbyl or substituted hydrocarbyl-1H-pyrazole carboxylic acid or alkylenylcarboxylic acid or a hydrocarbyl or substituted hydrocarbyl sulfonamide of said carboxylic acid or said alkylenylcarboxylic acid, provided however said compound is not a 3-carboxylic acid, a sulfonamide thereof, or a 3-methylenylcarboxylic acid. The compound may be represented by the following formula
Wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, X, W, X and Y are as defined in the specification. The compounds may be administered to treat DP1, FP, EP1, TP and/or EP4 receptor mediated diseases or conditions.
本发明提供了一种化合物,该化合物是1-[(2-[(烷基或芳基)甲基]氧}卤代或卤代烷基取代的苯基)烷基]-5-烃基或取代烃基-1H-吡唑酸或烷基羧酸或所述羧酸的烷基烯基羧酸或所述烷基烯基羧酸的烃基或取代烃基磺酰胺,但是所述化合物不是3-羧酸,其磺酰胺或3-亚甲基羧酸。该化合物可以用以下公式表示
其中R1,R2,R3,R4,R5,R6,X,W,X和Y在说明书中定义。这些化合物可以用于治疗DP1、FP、EP1、TP和/或EP4受体介导的疾病或病症。